UK Biotech News - Latest Headlines
May 31, 2025
Newcastle-based Iksuda Therapeutics has announced a key clinical milestone with the dosing of the first patient in its Phase 1 trial of IKS03, a CD19-targeting antibody-drug conjugate (ADC) developed for patients with -Continue Reading
May 30, 2025
Xyme, a next-generation enzyme design company, has moved into the newly completed Inventa building at Oxford’s West End, taking up 5,600 sq ft of research and office space. The lease was secured -Continue Reading
May 30, 2025
Cambridge-based biotech Gene Weaver has secured a $515,000 (approx. £405,000) grant from the Bill & Melinda Gates Foundation to progress its programmable gene insertion technology - an emerging platform designed to enable -Continue Reading
May 27, 2025
BioNTech is significantly expanding its UK footprint with a landmark investment and strategic partnership aimed at reshaping the landscape of medical innovation across the country.In a major boost for the UK life -Continue Reading
May 27, 2025
GSK has taken another strategic step in its biologics pipeline by submitting a New Drug Submission (NDS) to Health Canada for depemokimab, a monoclonal antibody aimed at two challenging inflammatory conditions: type -Continue Reading
May 26, 2025
The UK biotech industry is rapidly evolving, offering an expanding range of opportunities for professionals at every stage of their career. Whether you are a recent graduate, a postdoc, or a professional -Continue Reading
May 26, 2025
Orion Pharma, one of Finland’s leading pharmaceutical companies, is making a decisive move into the UK’s life sciences landscape with the launch of a new Biologics Research and Development Centre in Cambridge. -Continue Reading
May 24, 2025
Cambridge-based Alchemab Therapeutics has signed a licensing agreement with Eli Lilly and Company for its investigational neurodegeneration programme, ATLX-1282, in a deal worth up to $415 million.The agreement grants Lilly rights to -Continue Reading
May 24, 2025
Cambridge-based drug discovery firm sets sights on North American growthDomainex, a leading provider of drug discovery services, is making a strategic push into the US market with the launch of two new -Continue Reading
April 30, 2025
Imperial College London and Bruntwood SciTech have today announced a new partnership and unveiled a major new life science and deep tech innovation workspace in West London in a significant new investment in the Imperial -Continue Reading
